Document is current
Any future updates will be listed below
-
Authors
Srpova, Barbora https://orcid.org/0000-0002-8092-6625
Sobisek, Lukas
Novotna, Klara
Uher, Tomas
Friedova, Lucie
Vaneckova, Manuela
Krasensky, Jan
Kubala Havrdova, Eva
Horakova, Dana
- License Information
-
More Information
Article History
Received: 25 January 2021
Accepted: 31 July 2021
First Online: 15 August 2021
Declarations
:
: The study received ethical approval from the local ethical committee of General University Hospital in Prague.
: Signed informed consent was obtained from all participants.
: Not applicable.
: Barbora Srpova has received compensation for travelling and conference fees from Novartis, Sanofi Genzyme and Biogen Idec. Lukas Sobisek has received financial support from Novartis. Tomas Uher has received financial support for conference travel and honoraria from Biogen Idec, Roche, Novartis, Genzyme, and Merck Serono, as well as support for research activities from Biogen Idec and Sanofi (GZ-2017–11718). Eva Kubala Havrdova has received speaker honoraria and consultant fees from Biogen Idec, Merck Serono, Novartis, Genzyme, and Teva, as well as support for research activities from Biogen Idec and Merck Serono. Dana Horakova has received compensation for travel, speaker honoraria, and consultant fees from Biogen Idec, Novartis, Merck, Bayer, Sanofi Genzyme, and Teva, as well as support for research activities from Biogen Idec. Manuela Vaneckova has received compensation for travel, speaker honoraria, and consultant fees from Biogen Idec, Novartis, and Sanofi Genzyme, as well as support for research activities from Biogen Idec.
